USD0.000æéå€ååŒÂ  (ET)
1.29BæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
Integra Lifesciences Holdings Corp
äž»èŠããŒã¿
17.150å§å€
17.590é«å€
935.09Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
6.35äºæ³PER
--çŽè¿12ã¶æé
åœ
1.20%売買å転ç
17.120忥çµå€
16.240å®å€
11.95M売買代é
æå€±é¡æ ªäŸ¡åçç
1.24PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-13.00%ç·è³ç£å©çç
16.62052é±é«å€
0.63åºæ¥é«æ¯ç%
-6.94MçŽå©ç
77.89Mæ ªåŒæ°
-6.46541æ ªåœããå©çïŒEPSïŒ
1.23ããŒã¿å€
-38.64%èªå·±è³æ¬å©çç
8.70052é±å®å€
7.89%æ¯ãå¹
54.90%ç²å©çç
1.29BæäŸ¡ç·é¡
-1.70ãªã¹ã¯ãªã¿ãŒã³
3.43%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Integra Lifesciences Holdings Corpã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå®å®ã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»çæ©åš & å忥çã§ã®é äœã¯199äž65äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯20.00ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããæ ªåŒåžå Žã§ã®ããã©ãŒãã³ã¹ã¯ãã®1ãæã§äœèª¿ã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Integra Lifesciences Holdings Corpã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Integra Lifesciences Holdings Corpã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Integra Lifesciences Holdings Corp ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Integra Lifesciences Holdings Corp
IART
12
Zimmer Biomet Holdings Inc
ZBH
31
ææšî
ææš
売ã(3)
äžç«(2)
è²·ã(0)
ç§»åå¹³å
売ã(4)
äžç«(0)
è²·ã(2)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Integra Lifesciences Holdings Corpã®äŒæ¥æ
å ±î
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
äŒæ¥ã³ãŒãIART
äŒæ¥åIntegra Lifesciences Holdings Corp
æé«çµå¶è²¬ä»»è
ãCEOãPoul (Mojdeh)
ãŠã§ããµã€ãhttps://www.integralife.com/
æ ªäž»çµ±èšî
ãããã質å
Integra Lifesciences Holdings CorpïŒIARTïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îIntegra Lifesciences Holdings CorpïŒIARTïŒã®çŸåšã®æ ªäŸ¡ã¯16.65ã§ãã
Integra Lifesciences Holdings Corpã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îIntegra Lifesciences Holdings Corpã®ãã£ãã«ãŒã·ã³ãã«ã¯IARTã§ãã
Integra Lifesciences Holdings Corpã®52é±é«å€ã¯ãããã§ããïŒ
îIntegra Lifesciences Holdings Corpã®52é±é«å€ã¯16.62ã§ãã
Integra Lifesciences Holdings Corpã®52é±å®å€ã¯ãããã§ããïŒ
îIntegra Lifesciences Holdings Corpã®52é±å®å€ã¯8.70ã§ãã
Integra Lifesciences Holdings Corpã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îIntegra Lifesciences Holdings Corpã®æäŸ¡ç·é¡ã¯1.29Bã§ãã
Integra Lifesciences Holdings Corp (IART) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãIntegra Lifesciences Holdings CorpïŒIARTïŒã®ç·åè©äŸ¡ã¯signal_holdã§ãç®æšæ ªäŸ¡ã¯20.00ã§ãã
Integra Lifesciences Holdings Corp (IART) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îIntegra Lifesciences Holdings CorpïŒIARTïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-6.74ã§ãã